对于慢性丙型肝炎干扰素治疗无反应者，采用r-干扰素α-2b/利巴韦林联合治疗，随后给予低剂量r-干扰素α-2b。 - Suppr | 超能文献

r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.

作者信息

Perasso A, Testino G, Ansaldi F, Venturino V, Icardi G C

出版信息

Hepatology. 1999 Jan;29(1):297-8. doi: 10.1002/hep.510290135.

DOI:10.1002/hep.510290135

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.对于慢性丙型肝炎干扰素治疗无反应者，采用r-干扰素α-2b/利巴韦林联合治疗，随后给予低剂量r-干扰素α-2b。

Hepatology. 1999 Jan;29(1):297-8. doi: 10.1002/hep.510290135.

2

[Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].[慢性丙型肝炎的治疗：单用干扰素α-2b或与利巴韦林联合使用]

Gastroenterol Clin Biol. 1999 Apr;23(4):541-4.

3

[Ribavirin in combination with interferon alpha-2b in the treatment of chronic hepatitis C].利巴韦林联合干扰素α-2b治疗慢性丙型肝炎

Presse Med. 2001 Feb 24;30(7):335-6.

4

Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to pegylated interferon alfa-2b and ribavirin.对于聚乙二醇化干扰素α-2b和利巴韦林治疗无应答的慢性丙型肝炎患者，使用共识干扰素和利巴韦林进行治疗。

Dig Dis Sci. 2008 Jul;53(7):1961-6. doi: 10.1007/s10620-007-0076-y. Epub 2008 Jan 25.

5

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.干扰素α-2b单独或联合利巴韦林作为慢性丙型肝炎的初始治疗。肝炎介入治疗组。

N Engl J Med. 1998 Nov 19;339(21):1485-92. doi: 10.1056/NEJM199811193392101.

6

Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.在对单独使用干扰素无反应的慢性丙型肝炎患者中，利巴韦林与干扰素α-n3序贯给药与联合给药的比较：一项随机对照试验的结果

Hepatology. 1998 Aug;28(2):341-6. doi: 10.1002/hep.510280208.

7

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.单用干扰素α-2b或联合利巴韦林治疗慢性丙型肝炎复发。国际肝炎介入治疗组

N Engl J Med. 1998 Nov 19;339(21):1493-9. doi: 10.1056/NEJM199811193392102.

8

High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.高剂量干扰素-α 2b联合利巴韦林治疗GB病毒-C/庚型肝炎病毒感染——一项针对慢性丙型肝炎患者的研究

Hepatogastroenterology. 2003 Mar-Apr;50(50):449-52.

9

Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.组合干扰素α-2b/利巴韦林疗法在慢性丙型肝炎复发患者和初治患者中的安全性。

Semin Liver Dis. 1999;19 Suppl 1:67-75.

10

Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.用干扰素α和利巴韦林治疗慢性丙型肝炎病毒感染：两名依赖输血的地中海贫血患者获得持续应答。

Med J Malaysia. 2002 Sep;57(3):353-6.

引用本文的文献

1

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.干扰素用于对干扰素无反应及复发的慢性丙型肝炎患者。

Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD003617. doi: 10.1002/14651858.CD003617.pub2.

2

Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy.“低剂量”利巴韦林与干扰素α-2a联合治疗，继以干扰素α-2a单药治疗用于慢性丙型肝炎病毒感染患者，这些患者在接受干扰素α-2a单药治疗后无应答或复发。

World J Gastroenterol. 2001 Apr;7(2):222-7. doi: 10.3748/wjg.v7.i2.222.

3

Treatment of chronic hepatitis C in nonresponders to interferon monotherapy.对干扰素单一疗法无反应的慢性丙型肝炎的治疗

Curr Gastroenterol Rep. 2000 Feb;2(1):11-7. doi: 10.1007/s11894-000-0046-4.